Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BR-1018 by Boryung Pharmaceutical for Hypercholesterolemia: Likelihood of Approval
BR-1018 is under clinical development by Boryung Pharmaceutical and currently in Phase III for Hypercholesterolemia. According to GlobalData, Phase III...
Data Insights
BR-1018 by Boryung Pharmaceutical for Idiopathic (Essential) Hypertension: Likelihood of Approval
BR-1018 is under clinical development by Boryung Pharmaceutical and currently in Phase III for Idiopathic (Essential) Hypertension. According to GlobalData,...